EASL Studio S6 E9
Wednesday 20 March, 18:00 CET
Therapy hierarchy in HCC: A new kid on the block
EASL Molecular Tumour Board
On demand!
Catch up with the presentation and discussion of this clinical case of cholangiocarcinoma.
EASL Journal Club
23 April 2024, 18:00 CET
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
EASL Policy Dialogues
Season 3 Episode 1 now available!
Rarity and parity – Addressing inequities in rare liver disease
Steatotic liver disease – the missing piece in the NCD puzzle
Now on-demand!
Discover the priorities and recommendations for the upcoming WHA77 agenda established by EASL, representatives from the WHO, patient advocate, NCD Alliance, and more !
You may also be interested in
Our Sponsors